News & Updates

Show Multimedia Only

Saffron serves up benefits for patients with ulcerative colitis

16 Feb 2024 by

Saffron supplements show promise in managing ulcerative colitis (UC), with notable effects on inflammatory markers and clinical manifestations of the disease, as reported in a small study.

Saffron serves up benefits for patients with ulcerative colitis

16 Feb 2024

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

16 Feb 2024 by

In Asian patients with esophageal squamous cell carcinoma (ESCC), adding the TIGIT inhibitor tiragolumab and PD-L1 inhibitor atezolizumab to chemotherapy improved all outcomes in the phase III SKYSCRAPER-08 trial.

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

16 Feb 2024

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

16 Feb 2024

In patients with primary biliary cholangitis (PBC), elevated total cholesterol levels are associated with dysregulation of lipid metabolism and may lead to poor clinical outcomes, as shown in a study.

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

16 Feb 2024

Original New Drug Application Approvals by US FDA (01-15 February 2024)

16 Feb 2024

New drug applications approved by US FDA as of 01-15 February 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 February 2024)

16 Feb 2024

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

15 Feb 2024

Exposure to potassium-competitive acid blockers (PCABs) may heighten the risk of developing gastric cancer after successful treatment for Helicobacter pylori infection, according to a study.

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

15 Feb 2024

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis

15 Feb 2024

Abstinence from alcohol may dramatically increase survival rates for individuals with alcohol-related cirrhosis, as reported in a study.

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis

15 Feb 2024

IBD patients see improvements after surgical intervention

15 Feb 2024 by

A surgical intervention performed for inflammatory bowel disease (IBD) appears to confer favourable effects on patient-reported outcomes such as pain and overall health, according to a prospective, longitudinal cohort study.

IBD patients see improvements after surgical intervention

15 Feb 2024

Double whammy: Depression and IBD increase hospital readmission, death

15 Feb 2024 by

Individuals with comorbid depression and inflammatory bowel disease (IBD) are at increased risks for hospital readmission and mortality at 30 days after readmission as shown in a retrospective observational study presented at CCC 2024.

Double whammy: Depression and IBD increase hospital readmission, death

15 Feb 2024

Risk of PFCs lower with anti-TNF therapy if given early

14 Feb 2024 by

Early treatment with tumour necrosis factor (TNF) inhibitors lowers the risk of perianal fistulizing complications (PFCs) in children and teens compared with no immunosuppression or immunomodulators without TNF inhibitors in a post-hoc analysis of a prospective observational study.

Risk of PFCs lower with anti-TNF therapy if given early

14 Feb 2024

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024 by

In the EMERALD-1 trial, durvalumab plus bevacizumab (D+B) combined with transarterial chemoembolization (TACE) improved progression-free survival (PFS) in individuals with unresectable hepatocellular carcinoma (HCC) eligible for embolization.

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

13 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Saffron serves up benefits for patients with ulcerative colitis

Saffron serves up benefits for patients with ulcerative colitis

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

SKYSCRAPER-08 hits mark in ESCC with dual checkpoint inhibition + doublet chemo

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

Hypercholesterolemia linked to poor prognosis in primary biliary cholangitis

Original New Drug Application Approvals by US FDA (01-15 February 2024)

Original New Drug Application Approvals by US FDA (01-15 February 2024)

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Potassium-competitive acid blockers linked to gastric cancer risk after H pylori eradication

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis

Alcohol abstinence boosts overall survival in alcohol-associated cirrhosis

IBD patients see improvements after surgical intervention

IBD patients see improvements after surgical intervention

Double whammy: Depression and IBD increase hospital readmission, death

Double whammy: Depression and IBD increase hospital readmission, death

Risk of PFCs lower with anti-TNF therapy if given early

Risk of PFCs lower with anti-TNF therapy if given early

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape

Immunotherapy, TACE-based regimen may reshape HCC treatment landscape